找回密碼
 To register

QQ登錄

只需一步,快速開始

掃一掃,訪問微社區(qū)

打印 上一主題 下一主題

Titlebook: Hematologic Challenges in the Critically Ill; Aryeh Shander,Howard L. Corwin Book 2018 Springer International Publishing AG, part of Sprin

[復(fù)制鏈接]
樓主: 母牛膽小鬼
41#
發(fā)表于 2025-3-28 17:50:38 | 只看該作者
42#
發(fā)表于 2025-3-28 21:33:24 | 只看該作者
43#
發(fā)表于 2025-3-29 02:02:46 | 只看該作者
Hematologic Challenges in ICU Patients with Malignancy,den. Oncogenes activate blood coagulation as an integral feature of neoplastic transformation whereby cancer cells support clot formation and clotting proteins support cancer growth and dissemination. A complex coagulopathy develops characterized by activation of clotting mechanisms to different ext
44#
發(fā)表于 2025-3-29 03:06:22 | 只看該作者
45#
發(fā)表于 2025-3-29 08:01:06 | 只看該作者
46#
發(fā)表于 2025-3-29 13:37:17 | 只看該作者
Current Risks of Transfusion,al risks. Over time, the risks associated with transfusion have become increasingly well understood. However, most clinicians think only of transfusion-transmitted infections such as hepatitis B and C and human immunodeficiency virus in regard to transfusion risk. There are many other transfusion ri
47#
發(fā)表于 2025-3-29 17:19:09 | 只看該作者
Clinical Outcomes and Red Blood Cell Storage, blood cell transfusions (Shehata et al. Transfusion 54:2631-9, 2014; Vincent, JAMA 288:1499-507, 2002; Corwin, Crit Care Med 32:39-52, 2004). Our understanding of the biochemical, structural, and functional changes that occurs to red blood cells with storage – also known as the storage lesion – has
48#
發(fā)表于 2025-3-29 19:43:11 | 只看該作者
49#
發(fā)表于 2025-3-30 01:12:39 | 只看該作者
Therapeutic Apheresis for Hematologic Emergencies,s, most often discarding one (red cells, plasma, white cells, or platelets); and returned to the patient with or without extracorporeal modification or a replacement fluid. Multiple TA modalities can be used in the intensive care setting including therapeutic plasma exchange, red blood cell exchange
50#
發(fā)表于 2025-3-30 06:57:30 | 只看該作者
Intravenous Oxygen Therapeutics: A Revolution in Medicine Yet to Be Realized?,has pursued an oxygen therapeutic since the early 1930s with actually some spotty points of success. There are places in the world today that such agents are available, but they have not realized their potential. Two distinctly different pharmaceutical approaches are under accelerated development: h
 關(guān)于派博傳思  派博傳思旗下網(wǎng)站  友情鏈接
派博傳思介紹 公司地理位置 論文服務(wù)流程 影響因子官網(wǎng) 吾愛論文網(wǎng) 大講堂 北京大學(xué) Oxford Uni. Harvard Uni.
發(fā)展歷史沿革 期刊點(diǎn)評 投稿經(jīng)驗(yàn)總結(jié) SCIENCEGARD IMPACTFACTOR 派博系數(shù) 清華大學(xué) Yale Uni. Stanford Uni.
QQ|Archiver|手機(jī)版|小黑屋| 派博傳思國際 ( 京公網(wǎng)安備110108008328) GMT+8, 2025-10-9 03:46
Copyright © 2001-2015 派博傳思   京公網(wǎng)安備110108008328 版權(quán)所有 All rights reserved
快速回復(fù) 返回頂部 返回列表
邹平县| 克山县| 湟中县| 尤溪县| 历史| 河池市| 大渡口区| 皋兰县| 罗平县| 大冶市| 建湖县| 吉林市| 平山县| 杂多县| 尼玛县| 驻马店市| 伊金霍洛旗| 大连市| 中阳县| 张掖市| 大足县| 抚顺市| 板桥市| 阿克苏市| 北川| 合江县| 宁武县| 浪卡子县| 慈溪市| 大方县| 丹东市| 灵璧县| 乐都县| 故城县| 蒙阴县| 正定县| 当涂县| 金川县| 夏河县| 襄垣县| 眉山市|